The use of rituximab therapy in patients with acquired factor V inhibitors.
Department of Hematology, Alvarez General Hospital, Buenos Aires, Argentina.American Journal of Hematology (Impact Factor: 4). 04/2012; 87(8):826-7. DOI:10.1002/ajh.23241
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual current impact factor. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.